A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

被引:64
|
作者
Mahoney, Christopher E. [1 ]
Pirman, David [1 ]
Chubukov, Victor [1 ]
Sleger, Taryn [1 ]
Hayes, Sebastian [1 ]
Fan, Zi Peng [1 ]
Allen, Eric L. [1 ]
Chen, Ying [2 ]
Huang, Lingling [2 ]
Liu, Meina [2 ]
Zhang, Yingjia [2 ]
McDonald, Gabrielle [1 ]
Narayanaswamy, Rohini [1 ]
Choe, Sung [1 ]
Chen, Yue [1 ]
Gross, Stefan [1 ]
Cianchetta, Giovanni [1 ]
Padyana, Anil K. [1 ]
Murray, Stuart [1 ]
Liu, Wei [1 ]
Marks, Kevin M. [1 ]
Murtie, Joshua [1 ]
Dorsch, Marion [1 ]
Jin, Shengfang [1 ]
Nagaraja, Nelamangala [1 ]
Biller, Scott A. [1 ]
Roddy, Thomas [1 ]
Popovici-Muller, Janeta [1 ,3 ]
Smolen, Gromoslaw A. [1 ,4 ]
机构
[1] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA
[2] Shanghai ChemPartner Co Ltd, 998 Halei Rd, Shanghai 201203, Peoples R China
[3] Decibel Therapeut, 1325 Boylston St,Suite 500, Boston, MA 02215 USA
[4] Celsius Therapeut, 215 First St, Cambridge, MA 02142 USA
关键词
SQUALENE EPOXIDASE; LUNG-CANCER; CHOLESTEROL; METABOLISM; SENSITIVITY; ONCOGENE; ASCL1; LEADS; D2O;
D O I
10.1038/s41467-018-07959-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging. We conducted a chemical biology screen and identified a subset of neuroendocrine tumors displaying a striking pattern of sensitivity to inhibition of the cholesterol biosynthetic pathway enzyme squalene epoxidase (SQLE). Using a variety of orthogonal approaches, we demonstrate that sensitivity to SQLE inhibition results not from cholesterol biosynthesis pathway inhibition, but rather surprisingly from the specific and toxic accumulation of the SQLE substrate, squalene. These findings highlight SQLE as a potential therapeutic target in a subset of neuroendocrine tumors, particularly small cell lung cancers.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation
    Hatano, Koji
    Kumar, Binod
    Zhang, Yonggang
    Coulter, Jonathan B.
    Hedayati, Mohammad
    Mears, Brian
    Ni, Xiaohua
    Kudrolli, Tarana A.
    Chowdhury, Wasim H.
    Rodriguez, Ronald
    DeWeese, Theodore L.
    Lupold, Shawn E.
    NUCLEIC ACIDS RESEARCH, 2015, 43 (08) : 4075 - 4086
  • [42] RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment
    Li, Feifei
    Gong, Hang
    Jia, Xinfei
    Gao, Chang
    Jia, Peng
    Zhao, Xin
    Chen, Wenxia
    Wang, Lili
    Xue, Nina
    PHARMACEUTICALS, 2024, 17 (11)
  • [43] A chemical biology screen identifies glucocorticoids as inhibitors of C-Maf and C-Maf-dependent transactivation of cyclin D2.
    Mao, Xinliang
    Keith Stewart, A.
    Hurren, Rose
    Datti, Alessandro
    Shi, Chang Xin
    Zhu, Yuan-Xiao
    Lee, Kyle
    Tiedemann, Rodger
    Eberhard, Yanina
    Corey, Seth J.
    Wrana, Jeff
    Schimmer, Aaron D.
    BLOOD, 2006, 108 (11) : 113A - 113A
  • [44] Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures
    Bodle, Christopher R.
    Schamp, Josephine H.
    O'Brien, Joseph B.
    Hayes, Michael P.
    Wu, Meng
    Doorn, Jonathan A.
    Roman, David L.
    SLAS DISCOVERY, 2018, 23 (04) : 363 - 374
  • [45] A CRISPR/Cas9 knockout screen identifies NAD plus kinase as a metabolic vulnerability in BCAT1 overexpressing AML cells
    Chung, L.
    Antes, M.
    Besiridou, E.
    Monnig, M.
    Demir, A.
    Janssen, M.
    Mueller-Tidow, C.
    Raffel, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 114 - 114
  • [46] Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
    Mertens, Sander
    Huismans, Maarten A.
    Verissimo, Carla S.
    Ponsioen, Bas
    Overmeer, Rene
    Proost, Natalie
    van Tellingen, Olaf
    van de Ven, Marieke
    Begthel, Harry
    Boj, Sylvia F.
    Clevers, Hans
    Roodhart, Jeanine M. L.
    Bos, Johannes L.
    Snippert, Hugo J. G.
    CELL REPORTS, 2023, 42 (04):
  • [47] Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells
    Raymond, Aaron C.
    Gao, Boning
    Girard, Luc
    Minna, John D.
    Udugamasooriya, D. Gomika
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells
    Chiara Ghezzi
    Alicia Wong
    Bao Ying Chen
    Bernard Ribalet
    Robert Damoiseaux
    Peter M. Clark
    Nature Communications, 10
  • [49] Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells
    Aaron C. Raymond
    Boning Gao
    Luc Girard
    John D. Minna
    D. Gomika Udugamasooriya
    Scientific Reports, 9
  • [50] Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways
    Aarts, Marieke
    Bajrami, Ilirjana
    Herrera-Abreu, Maria T.
    Elliott, Richard
    Brough, Rachel
    Ashworth, Alan
    Lord, Christopher J.
    Turner, Nicholas C.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (04) : 865 - 876